Clinical Trials in Detroit

Showing 6441-6460 of 19,719 trials

Preventing Substance Use Among Youth

NCT04752189

Using a 2-group, mixed method group randomized trial design, this pilot study will compare standard implementation versus Enhanced Replicating Effective Programs (Enhanced REP) to deliver Michigan Model for Health (MMH) in Michigan high schools.

Substance Abuse

Wayne State University825 participantsStarted Aug 2021

Detroit, Michigan, United States

COMPLETEDPhase 2< 1 mile

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

NCT02639182

The purpose of this study was to evaluate the progression free survival (PFS), based on investigator radiologic review, of AGS-16C3F compared to axitinib in subjects with metastatic renal cell carcinoma.

Metastatic Renal Cell Carcinoma

Astellas Pharma Global Development, Inc.133 participantsStarted May 2016

Tucson, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +23 more locations

Preventing Substance Use Among Youth

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

Find Trials by Condition in Detroit

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Feasibility of Semi-Permanent Tattoo for Treatment Alignment in Radiation Therapy

Neuromodulation of Conscious Perception: Investigating Thalamic Roles Through Ultrasonic Stimulation

Pediatric Adenotonsillectomy Trial for Snoring

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

Extravascular ICD Pivotal Study

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Zip-Stitch® in Minimally-Invasive Surgery (ZIMS) - Safety & Efficacy in Hysterectomy

A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread

To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers